Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Biomatrop
- Development stage
- Phase 4
- Lead developer
- Ache Pharmaceutical
- Modality
- Recombinant Proteins and Enzymes
- Administration
- Subcutaneous
01
Overview
**Biomatrop** is a brand name for somatropin, a recombinant human growth hormone used to treat growth hormone deficiency and related conditions. It mimics endogenous growth hormone by binding to growth hormone receptors on target cells, stimulating the production of insulin-like growth factor 1 (IGF-1) primarily in the liver, which promotes longitudinal growth in children, regulates metabolism, and maintains body composition in adults. Developed and manufactured by Ache Laboratorios Farmaceuticos S/A, it is administered via subcutaneous injection and has been evaluated in clinical studies for pain intensity compared to other somatropin products like Hormotrop.
- Brand names
- Biomatrop
- Other names
- Hormotrop
02
Targets
GHR (Growth hormone receptor)
Beyond the preview
Go deeper on Biomatrop.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Biomatrop.